The FDA’s policies would boost the black market and smoking-related deaths

Redlands Daily Facts cites CEI Senior Fellow Michelle Minton on menthol flavored cigarettes:

Beyond that specific controversy, the FDA has rejected millions of applications for vaping products in nontobacco flavors, including menthol. Yet its cost-benefit analysis of the proposed ban on menthol cigarettes assumes the availability of e-cigarette alternatives.

As Competitive Enterprise Institute senior fellow Michelle Minton points out, the FDA relies on a study in which “the substitution of high-risk combustible menthol cigarettes for lower-risk menthol-flavored nicotine vapor products … accounts for approximately half of the benefits.” How are menthol smokers supposed to make that switch if the FDA refuses to allow the sale of menthol-flavored e-cigarettes?

More generally, the FDA’s bias against flavor variety is hard to reconcile with its concession that vaping has great potential to reduce smoking-related disease and death. An arbitrary ban on the flavors that adult consumers demonstrably prefer will drive some people back to smoking and discourage current smokers from switching.

Read the full article here.